N Vardakis Selected Research

Neoplasms (Cancer)

7/2012	Paclitaxel in combination with carboplatin as salvage treatment in patients with castration-resistant prostate cancer: a Hellenic oncology research group multicenter phase II study.
2/2012	Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study.
11/2011	Efficacy and treatment tolerance in older patients with NSCLC: a meta-analysis of five phase III randomized trials conducted by the Hellenic Oncology Research Group.
4/2011	Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
12/2008	Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel-gemcitabine chemotherapy.
4/2007	Dose escalating clinical study of high dose infusional 5-fluorouracil and leukovorin (AIO regimen) plus alternate weekly administration of oxaliplatin and irinotecan in patients with advanced tumors of the gastrointestinal tract.
1/2006	A dose escalation study of biweekly oral vinorelbine and gemcitabine in patients with solid tumors.
1/2006	A dose-escalation study of pegylated liposomal Doxorubicin and oxaliplatin in patients with advanced solid tumors.
1/2006	A dose escalation study of gemcitabine plus pemetrexed administered biweekly in patients with solid tumors.
1/2005	Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer: A phase II trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N Vardakis Research Topics

Disease

16	Neoplasms (Cancer) 07/2012 - 01/2000
10	Neutropenia 03/2017 - 01/2000
8	Colorectal Neoplasms (Colorectal Cancer) 12/2012 - 01/2001
7	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2000
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2017 - 05/2001
3	Diarrhea 03/2017 - 01/2004
3	Disease Progression 01/2015 - 01/2007
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 06/2010 - 01/2001
3	Febrile Neutropenia 01/2006 - 01/2000
2	Vomiting 01/2006 - 01/2006
2	Nausea 01/2006 - 01/2006
2	Stomach Neoplasms (Stomach Cancer) 08/2004 - 08/2000
2	Asthenia 01/2004 - 02/2003
2	Ovarian Neoplasms (Ovarian Cancer) 01/2002 - 01/2001
1	Neoplasm Metastasis (Metastasis) 12/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2012
1	Esophagitis 06/2010
1	Exanthema (Rash) 01/2007
1	Mucositis 02/2003
1	Thrombocytopenia (Thrombopenia) 02/2003
1	Fatigue 01/2001

Drug/Important Bio-Agent (IBA)

12	Irinotecan (Camptosar)FDA LinkGeneric 03/2017 - 01/2001
12	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2012 - 02/2000
8	Docetaxel (Taxotere)FDA Link 01/2015 - 01/2000
8	Gemcitabine FDA Link 01/2015 - 02/2000
7	Fluorouracil (Carac)FDA LinkGeneric 12/2012 - 01/2001
6	Leucovorin (Folinic Acid)FDA Link 12/2012 - 01/2001
4	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 12/2001
4	thiamine triphosphorate (TTP)IBA 07/2012 - 01/2005
3	taxaneIBA 02/2013 - 01/2000
3	Vinorelbine (Navelbine)FDA LinkGeneric 04/2011 - 01/2002
3	Capecitabine (Xeloda)FDA Link 01/2008 - 01/2004
2	Pemetrexed (MTA)FDA Link 03/2017 - 01/2006
2	Bevacizumab (Avastin)FDA Link 01/2015 - 04/2011
2	Messenger RNA (mRNA)IBA 02/2013 - 06/2003
2	Cetuximab (Erbitux)FDA Link 12/2012 - 02/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 07/2012 - 01/2000
2	Etoposide (VP 16)FDA LinkGeneric 06/2010 - 01/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2003 - 01/2001
1	PlatinumIBA 03/2017
1	Carboplatin (JM8)FDA LinkGeneric 07/2012
1	Prednisone (Sone)FDA LinkGeneric 07/2012
1	AnthracyclinesIBA 05/2012
1	Taxoids (Taxanes)IBA 05/2012
1	Peptides (Polypeptides)IBA 02/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2012
1	human telomerase reverse transcriptase p572YIBA 02/2012
1	VaccinesIBA 02/2012
1	ErbB Receptors (EGF Receptor)IBA 02/2007
1	Monoclonal AntibodiesIBA 02/2007
1	Immunoglobulin G (IgG)IBA 02/2007
1	Gefitinib (Iressa)FDA Link 01/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	Aligeron (AS 2)IBA 01/2006
1	1-dodecylpyridoxal (PLD)IBA 01/2006
1	liposomal doxorubicin (Doxil)FDA Link 01/2006
1	Keratin-19 (Keratin 19)IBA 06/2003
1	EnzymesIBA 01/2001
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2000

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 03/2017 - 01/2000
7	Salvage Therapy 03/2017 - 01/2005
6	Treatment Delay 01/2006 - 01/2000
3	Therapeutics 01/2008 - 01/2001
1	CP protocol 03/2017
1	Castration 07/2012
1	Radiotherapy 06/2010
1	Consolidation Chemotherapy 06/2010
1	Adjuvant Chemotherapy 06/2003